Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-058133)

Filing Details

Accession Number:: 0001209191-13-058133
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-20 14:44:18
Reporting Period:: 2013-12-19

Filing Date:: 2013-12-20
Accepted Time:: 2013-12-20 14:44:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949699	Pharmacyclics Inc	PCYC	Pharmaceutical Preparations (2834)	943148201

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555167	Heow Tan	C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085	Chief Quality&Tech Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-19	5,000	$27.05	5,169	No	4	M	Direct
Common Stock	Disposition	2013-12-19	3,000	$100.93	2,169	No	4	S	Direct
Common Stock	Disposition	2013-12-19	2,000	$100.78	169	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-12-19	5,000	$0.00	5,000	$27.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
90,000	2012-05-07	2022-05-07	No	4	M	Direct

Footnotes

The option shares vest 25% on each of April 11, 2013, April 11, 2014, April 11, 2015 and April 11, 2016, subject to satisfaction of certain performance criteria with respect to each vesting period. Such performance criteria is to be determined and approved by the Compensation Committee.